Skip to search formSkip to main contentSkip to account menu

GPS2 gene

Known as: G Protein Pathway Suppressor 2 Gene, G protein pathway suppressor 2, GPS2 
This gene plays a role in suppression of signal transduction.
National Institutes of Health

Related topics

Related topics

3 relations
GPS2 protein, humanMitotic Cell CycleSignal Repression

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Abstract P4-08-05: Novel tumor suppressor regulating the PI3K/AKT pathway in triple negative breast cancer (TNBC)
The PI3K/AKT signaling pathway is a known oncogenic pathway in breast cancer, involved in essential cellular processes necessary… 
Review
2018
Review
2018
Role of GPS2 in epigenome alterations linked to metaflammation
Current evidence suggests that transcriptional and epigenomic reprogramming events, triggered by transcription factors and… 
2018
2018
Le co-régulateur transcriptionnel GPS2 influence le remodelage et lâadaptation du tissu adipeux dans son expansion au cours de lâobésité et lâapparition du diabète de type 2
2016
2016
CA-140: Décodage des mécanismes épi-génomiques impliqués dans la susceptibilité au développement du diabète de type-2
2014
2014
Identification of an MLL4‐GPS2 fusion as an oncogenic driver of undifferentiated spindle cell sarcoma in a child
Undifferentiated spindle cell sarcoma (UDS) is a poorly defined or understood entity, essentially a waste‐basket for cases… 
2014
2014
Knockdown of a novel G-protein pathway suppressor 2 (GPS2) leads to shrimp mortality by exuvial entrapment during ecdysis.
2013
2013
GPS2 Is Required for the Association of NS5A with VAP-A and Hepatitis C Virus Replication
Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) is a component of the replication complex associated with various… 
2013
2013
P2141 La dérégulation du complexe répresseur SMRT/GPS2 induit l’inflammation adipocytaire dans l’obésité
2012
2012
PO40 Étude phénotypique des sous populations monocytaires au cours de l’obésité et de la perte de poids
2009
2009
Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
BACKGROUND Recent studies have revealed that the modified Glasgow Prognostic Score (mGPS), an inflammation-based prognostic score… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)